TugwellP., BoersM., BrooksP.OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials.2007. 8: 38.
2.
FriesJ.F., SpitzP., KrainesR.G., HolmanH.R.Measurement of patient outcome in arthritis. Arthritis Rheum.1980. 23: 137–45.
3.
AaronsonN., AlonsoJ., BurnamA.Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research.2002. 11: 193–205.
4.
PuzenatE., BronsardV., PreyS.What are the best outcome measures for assessing plaque psoriasis severity?A systematic review of the literature. J Eur Acad Dermatol Venereol.2010. 24(Suppl 2): 10–16.
5.
FeldmanS.R., KruegerG.G.Psoriasis assessment tools in clinical trials. Ann Rheum Dis.2005. 64(Suppl II): ii65–ii68.
6.
LangleyR.G., EllisC.N.Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol.2004. 51: 563–569.
7.
MrowietzU., KragballeK., ReichK.Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res.2011. 303: 1–10.
